Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Two promotions at Longitude Capital

This article was originally published in Scrip

Executive Summary

Longitude Capital (US) has promoted both Doug Foster and Dr David Hirsch to managing director. Mr Foster will continue to focus on investments in device companies for the fund, while Dr Hirsch will continue to focus on investments in biotechnology. Before he co-founded Longitude in 2006, Mr Foster was a vice-president in the life sciences practice at Pequot Venture. Dr Hirsch joined Longitude Capital in 2006 as co-founder after also previously as working at Pequot, where he was a vice-president in the life sciences practice.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

SC011463

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel